← FDA DRUG APPROVALS

FDA ANDA · ANDA083215

BROMPHENIRAMINE MALEATE

Sponsor: UPSHER SMITH LABS

APPLICATION
ANDA083215
TYPE
ANDA
ORIGINAL APPROVAL
1975-12-19
LATEST ACTION
1982-09-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BROMPHENIRAMINE MALEATEDiscontinued
BROMPHENIRAMINE MALEATE 4MG · TABLET · ORAL

Approval history

1982-09-30Manufacturing (CMC) · Supplement 29AP
1982-07-08Manufacturing (CMC) · Supplement 28AP
1982-07-01Manufacturing (CMC) · Supplement 27AP
1982-07-01Manufacturing (CMC) · Supplement 26AP
1982-04-15Manufacturing (CMC) · Supplement 25AP
1975-12-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →